Pfizer Canada strives to profoundly impact the health of Canadians through the discovery, development and delivery of medicines and vaccines. Our diverse portfolio offers a broad range of benefits and solutions to meet the needs of Canadians.
24.09.2024
Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine
19.09.2024
ABRYSVO™: Pfizer Canada’s Newly Publicly Funded Vaccine a Step Towards National RSV Prevention in Older Adults
22.08.2024
PADCEV® (enfortumab vedotin) in combination with pembrolizumab approved by Health Canada to treat advanced bladder cancer
12.08.2024
Pfizer Canada Ranked #1 by 100 Canadian Patient Advocacy Groups
03.06.2024
National Campaign Encourages Canadians to go “Out of Office” This Migraine Awareness Month